2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., Waku, K.·1995·Biochemical and Biophysical Research Communications

Cited by (1,009)

Items 901–1,000 of 1,009

  1. Cardiovascular effects of endocannabinoids—the plot thickens
    George Kunos, Zoltán Járai, Károly Varga, Jie Liu, Lei Wang, Jens A. Wagner · 2000 · Prostaglandins & Other Lipid Mediators
  2. The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential
    Mariana Coelho, Patrícia Duarte, Marta S. Calado, António José Almeida, Catarina Pinto Reis, Maria Manuela Gaspar · 2023 · Life Sciences
  3. Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed‐type hypersensitivity
    Jessica Margaret Sido, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2016 · European Journal of Immunology
  4. Endocannabinoid System Alterations in Posttraumatic Stress Disorder: A Review of Developmental and Accumulative Effects of Trauma
    Anahita Bassir Nia, Ricci L. Bender, Ilan Harpaz‐Rotem · 2019 · Chronic Stress
  5. Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1
    Dmitri Proudnikov, Thomas Kroslak, J.C. Sipe, Matthew Randesi, D Li, Sara Hamon, A. Ho, Jürg Ott, Mary Jeanne Kreek · 2009 · The Pharmacogenomics Journal
  6. New Perspectives in the Studies on Endocannabinoid and Cannabis: 2-Arachidonoylglycerol as a Possible Novel Mediator of Inflammation
    Takayuki Sugiura, Saori Oka, Maiko Gokoh, Seishi Kishimoto, Keizo Waku · 2004 · Journal of Pharmacological Sciences
  7. Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase
    Séverine Vandevoorde, Bijali Saha, Anu Mahadevan, Raj K. Razdan, Roger G. Pertwee, Billy R. Martin, Christopher John Fowler · 2005 · Biochemical and Biophysical Research Communications
  8. Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex
    Martin A. Sticht, Cheryl L. Limebeer, Benjamin R. Rafla, Rehab A. Abdullah, Justin L. Poklis, Winnie Ho, Micah J. Niphakis, Benjamin F. Cravatt, Keith A. Sharkey, Aron H. Lichtman et al. · 2015 · Neuropharmacology
  9. Silencing or Amplification of Endocannabinoid Signaling in Blastocysts via CB1 Compromises Trophoblast Cell Migration
    Huirong Xie, Xiaofei Sun, Yulan Piao · 2012 · Journal of Biological Chemistry
  10. Discovery and Development of Endocannabinoid-Hydrolyzing Enzyme Inhibitors
    Anna Minkkilä, Susanna M. Saario, Tapio Nevalainen · 2010 · Current Topics in Medicinal Chemistry
  11. The role of the endocannabinoid system in eating disorders
    Eva María Marco, Silvana‐Yanina Romero‐Zerbo, María‐Paz Viveros, Francisco Javier Bermúdez‐Silva · 2012 · Behavioural Pharmacology
  12. Recombinant Cannabinoid Type 2 Receptor in Liposome Model Activates G Protein in Response to Anionic Lipid Constituents
    Tomohiro Kimura, Alexei Yeliseev, Krishna Vukoti, Steven D. Rhodes, Kejun Cheng, Kenner C. Rice, Klaus Gawrisch · 2011 · Journal of Biological Chemistry
  13. 2-Arachidonoylglycerol (2-AG) Membrane Transport: History and Outlook
    Anita Hermann, Martin Kaczocha, Dale G. Deutsch · 2006 · The AAPS Journal
  14. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate
    Séverine Vandevoorde, Christopher John Fowler · 2005 · British Journal of Pharmacology
  15. Food for thought: endocannabinoid modulation of lipogenesis
    Aron H. Lichtman, Benjamin F. Cravatt · 2005 · Journal of Clinical Investigation
  16. The endocannabinoid system: function in survival of the embryo, the newborn and the neuron
    Ester Fride, Esther Shohami · 2002 · Neuroreport
  17. The contribution of lower vertebrate animal models in human reproduction research
    Rosanna Chianese, Teresa Chioccarelli, Giovanna Cacciola, Vincenza Ciaramella, Silvia Fasano, Riccardo Pierantoni, Rosaria Meccariello, Gilda Cobellis · 2010 · General and Comparative Endocrinology
  18. Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe/PS1ΔE9 double transgenic mice
    Sara Kalifa, Eva K. Polston, Joanne S. Allard, Kebreten F. Manaye · 2010 · Brain Research
  19. Accumulation of anandamide: Evidence for cellular diversity
    Cecilia J. Hillard, Abbas Jarrahian · 2005 · Neuropharmacology
  20. Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
    Rui S. Rodrigues, Diogo M. Lourenço, Sara L. Paulo, Joana M. Mateus, Miguel F. Ferreira, Francisco M. Mouro, João B. Moreira, Filipa F. Ribeiro, Ana Maria Sebastião, Sara Xapelli · 2019 · Molecules
  21. Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice
    Carmelo Quarta, Daniela Cota · 2020 · International Journal of Obesity
  22. The Immunopathology of COVID-19 and the Cannabis Paradigm
    Nicole Paland, Antonina Pechkovsky, Miran Aswad, Haya Hamza, Tania Popov, Eduardo Shahar, Igal Louria‐Hayon · 2021 · Frontiers in Immunology
  23. Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
    Ronit Vogt Sionov, Doron Steinberg · 2022 · Biomedicines
  24. Metabolic characterization of sciadonic acid (5c,11c,14c‐eicosatrienoic acid) as an effective substitute for arachidonate of phosphatidylinositol
    Tamotsu Tanaka, Jun‐ichi Morishige, Tatsunori Takimoto · 2001 · European Journal of Biochemistry
  25. The Endogenous Cannabinoid, Anandamide, Activates the Hypothalamo-Pituitary-Adrenal Axis in CB1 Cannabinoid Receptor Knockout Mice
    Tibor Wenger, Catherine A. Ledent, Gérard Tramu · 2003 · Neuroendocrinology
  26. The endocannabinoid 2-arachidonoylglycerol (2-AG) and metabolizing enzymes during rat fetoplacental development: A role in uterine remodelling
    Bruno Miguel Fonseca, Georgina Correia‐da‐Silva, Anthony Henry Taylor, Patricia M. W. Lam, Timothy H. Marczylo, S.C. Bell, Justin C. Konje, Natércia A. A. Teixeira · 2010 · The International Journal of Biochemistry & Cell Biology
  27. Identification of WIN55212‐3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor
    Juha R. Savinainen, Tarja Kokkola, Outi M. H. Salo‐Ahen, Antti Poso, Tomi Järvinen, Jarmo T. Laitinen · 2005 · British Journal of Pharmacology
  28. Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells
    Kasem Nithipatikom, Marilyn A. Isbell, Michael P. Endsley, Jeffrey E. Woodliff, William B. Campbell · 2010 · Prostaglandins & Other Lipid Mediators
  29. 15-Deoxy-Δ12,14-prostaglandin J2-Glycerol Ester, a Putative Metabolite of 2-Arachidonyl Glycerol, Activates Peroxisome Proliferator Activated Receptor γ
    Priyadarshini Raman, Barbara L.F. Kaplan, Jerry T. Thompson, John P. Vanden Heuvel, Norbert E. Kaminski · 2011 · Molecular Pharmacology
  30. Design, Synthesis, and Binding Studies of New Potent Ligands of Cannabinoid Receptors
    Antonella Brizzi, Vittorio Brizzi, Maria Grazia Cascio · 2005 · Journal of Medicinal Chemistry
  31. Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice
    Schlosburg, Joel E., Kinsey, Steven G., Ignatowska-Jankowska, Bogna, Ramesh, Divya, Abdullah, Rehab A., Tao, Qing, Booker, Lamont, Long, Jonathan Z., Selley, Dana E., Cravatt, Benjamin F. et al. · 2014 · The Journal of Pharmacology and Experimental Therapeutics
  32. Synthesis and structure–activity relationships of a series of pyrrole cannabinoid receptor agonists
    Giorgio Tarzia, Andrea Duranti, Andrea Tontini, Gilberto Spadoni, Marco Mor, Silvia Rivara, Pier Vincenzo Plazzi, Satish Kathuria, Daniele Piomelli · 2003 · Bioorganic & Medicinal Chemistry
  33. Endocannabinoids Generated by Ca2+ or by Metabotropic Glutamate Receptors Appear to Arise from Different Pools of Diacylglycerol Lipase
    Longhua Zhang, Meina Wang, Tiziana Bisogno, Vincenzo Di Marzo, Bradley E. Alger · 2011 · PLoS ONE
  34. VGluT3-Expressing CCK-Positive Basket Cells Construct Invaginating Synapses Enriched with Endocannabinoid Signaling Proteins in Particular Cortical and Cortex-Like Amygdaloid Regions of Mouse Brains
    Yuki Omiya, Motokazu Uchigashima, Kohtarou Konno, Miwako Yamasaki, Taisuke Miyazaki, Takayuki Yoshida, Ichiro Kusumi, Masahiko Watanabe · 2015 · Journal of Neuroscience
  35. Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas
    Ana Isabel Fraguas‐Sánchez, Ana María Fernández-Carballido, Ana Isabel Torres‐Suárez · 2016 · Expert Opinion on Investigational Drugs
  36. Inhibition of Diacylglycerol Lipase Impairs Fear Extinction in Mice
    Victoria S. Cavener, Andrew D. Gaulden, Dante Pennipede, Puja Jagasia, Jashim Uddin, Lawrence J. Marnett, Sachin Patel · 2018 · Frontiers in Neuroscience
  37. Opposing roles of CB1and CB2cannabinoid receptors in the stimulant and rewarding effects of cocaine
    Pedro Henrique Gobira, Ana Claudia Oliveira, Julia S. Gomes, Vívian T. da Silveira, Laila Asth, Juliana dos Reis Bastos, Edleusa Marques Batista, Ana Carolina Issy, Bright N. Okine, Antônio Carlos de Oliveira et al. · 2018 · British Journal of Pharmacology
  38. Communication and social interaction in the cannabinoid‐type 1 receptor null mouse: Implications for autism spectrum disorder
    William Fyke, Marika Premoli, Víctor Echeverry‐Alzate, José Antonio López‐Moreno, Valérie Lemaire, Wim E. Crusio, Giovanni Marsicano, Markus Wöhr, Susanna Pietropaolo · 2021 · Autism Research
  39. Simultaneous analysis of prostaglandin glyceryl esters and prostaglandins by electrospray tandem mass spectrometry
    Philip J. Kingsley, Carol A. Rouzer, Samir Saleh, Lawrence J. Marnett · 2005 · Analytical Biochemistry
  40. The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample
    Meliha Karsak, Ida Malkin, Mohammad Reza Toliat, Christian Kubisch, Peter Nürnberg, Andreas Zimmer, Gregory Livshits · 2009 · Human Genetics
  41. Endocannabinoid signaling and its regulation by nutrients
    Tiziana Bisogno, Mauro Maccarrone · 2014 · BioFactors
  42. Dual Inhibition of α/β-Hydrolase Domain 6 and Fatty Acid Amide Hydrolase Increases Endocannabinoid Levels in Neurons
    William Marrs, Eric A. Horne, Silvia Ortega‐Gutiérrez, Jose Antonio Cisneros, Cong Xu, Yi Hsing Lin, Giulio G. Muccioli, María Luz López-Rodríguez, Nephi Stella · 2011 · Journal of Biological Chemistry
  43. Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease
    Jessica Margaret Sido, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2014 · International Reviews of Immunology
  44. Diacylglycerol lipase disinhibits VTA dopamine neurons during chronic nicotine exposure
    Matthew W. Buczynski, Melissa A. Herman, Ku‐Lung Hsu, Luis A. Natividad, Cristina Irimia, Ilham Y. Polis, Holly M. Pugh, Jae Won Chang, Micah J. Niphakis, Benjamin F. Cravatt et al. · 2016 · Proceedings of the National Academy of Sciences
  45. Mass spectrometry profiling of oxylipins, endocannabinoids, and N-acylethanolamines in human lung lavage fluids reveals responsiveness of prostaglandin E2 and associated lipid metabolites to biodiesel exhaust exposure
    Sandra C. Gouveia-Figueira, Masoumeh Karimpour, Jenny A. Bosson, Anders Blomberg, Jon Unosson, Jamshid Pourazar, Thomas Sandström, Annelie Behndig, Malin Linder Nording · 2017 · Analytical and Bioanalytical Chemistry
  46. Δ 9 -Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult
    Leishman, Emma, Murphy, Michelle, Mackie, Ken, Bradshaw, Heather B. · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  47. Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
    Míriam Mecha, Francisco Javier Carrillo-Salinas, Ana Feliú, Leyre Mestre, Carmen Guaza · 2020 · Frontiers in Cellular Neuroscience
  48. Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
    Vamsi P. Reddy, Dayton P. Grogan, Meenakshi Ahluwalia, Évila Lopes Salles, Pankaj Kumar Ahluwalia, Hesam Khodadadi, Katelyn Alverson, Andy Nguyen, Srikrishnan P. Raju, Pankaj Gaur et al. · 2020 · The EPMA Journal
  49. Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2 H -benzo[ b ][1,4]oxazin-6-yl Moiety
    Shuhei Ikeda, Hideyuki Sugiyama, Hidekazu Tokuhara, Masataka Murakami, Minoru Nakamura, Yuya Oguro, Jumpei Aida, Nao Morishita, Satoshi Sogabe, Douglas R. Dougan et al. · 2021 · Journal of Medicinal Chemistry
  50. Cannabinoid Conditioned Reward and Aversion: Behavioral and Neural Processes
    Jennifer E. Murray, Rick A. Bevins · 2010 · ACS Chemical Neuroscience
  51. Novel Triaryl Sulfonamide Derivatives as Selective Cannabinoid Receptor 2 Inverse Agonists and Osteoclast Inhibitors: Discovery, Optimization, and Biological Evaluation
    Peng Yang, Liping Wang, Rentian Feng, Abdulrahman Abdulaziz Almehizia, Qin Tong, Kyaw-Zeyar Myint, Qin Ouyang, Mohammed Hamed Alqarni, Lirong Wang, Xiang‐Qun Xie · 2013 · Journal of Medicinal Chemistry
  52. Endocannabinoid Receptor Pharmacology
    Betty Bei Yao, Ken Mackie · 2009 · Current topics in behavioral neurosciences
  53. The effect of anandamide on prolactin secretion is modulated by estrogen
    Camila Scorticati, Claudia Ester Mohn, Andrea De Laurentiis, Paula Gabriela Vissio, Javier Fernández‐Solari, Adriana Seilicovich, Samuel M. McCann, Valéria Rettori · 2003 · Proceedings of the National Academy of Sciences
  54. Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice
    Gamage, Thomas F., Ignatowska-Jankowska, Bogna M., Muldoon, Pretal P., Cravatt, Benjamin F., Damaj, M. Imad, Lichtman, Aron H. · 2015 · Drug and Alcohol Dependence
  55. Liposomal Delivery of Diacylglycerol Lipase-Beta Inhibitors to Macrophages Dramatically Enhances Selectivity and Efficacy in Vivo
    Myungsun Shin, Helena W. Snyder, Giulia Donvito, Lesley D. Schurman, Todd E. Fox, Aron H. Lichtman, MARK A. KESTER, Ku‐Lung Hsu · 2017 · Molecular Pharmaceutics
  56. Endogenous lipid activated G protein-coupled receptors: Emerging structural features from crystallography and molecular dynamics simulations
    Dow P. Hurst, Marianne G. Schmeisser, Patricia H. Reggio · 2013 · Chemistry and Physics of Lipids
  57. The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission
    Silvia Rossi, Caterina Motta, Alessandra Musella, Diego Centonze · 2014 · Neuropharmacology
  58. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray
    Almeida-Santos, A.F., Gobira, P.H., Rosa, L.C., Guimaraes, F.S., Moreira, F.A., Aguiar, D.C. · 2013 · Behavioural Brain Research
  59. Computational insights into function and inhibition of fatty acid amide hydrolase
    Giulia Palermo, Ursula Röthlisberger, Andrea Cavalli, Marco De Vivo · 2014 · European Journal of Medicinal Chemistry
  60. Endocannabinoid signaling and energy metabolism: A target for dietary intervention
    Jeffrey J. Kim, Yong Li, Bruce A. Watkins · 2011 · Nutrition
  61. Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans
    Ana Beatriz Fagundo, Rafael de la Torre, Susana Jiménez‐Múrcia, Zaida Agüera, Antoni Pastor, Felipe F. Casanueva, Roser Granero, Rosa Baños, Cristina Botella, Amparo del Pino‐Gutiérrez et al. · 2013 · PLoS ONE
  62. Peripheral modulation of the endocannabinoid system in metabolic disease
    Nirajan Shrestha, James S. M. Cuffe, Dana S. Hutchinson, John Patrick Headrick, Anthony V. Perkins, Andrew J. McAinch, Deanne Helena Hryciw · 2018 · Drug Discovery Today
  63. Cannabinoid ligands, receptors and enzymes: Pharmacological tools and therapeutic potential
    Wafa Hourani, S P H Alexander · 2018 · Brain and Neuroscience Advances
  64. New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders
    María Scherma, Paolo Masia, Matteo Luca Deidda, Walter Fratta, Gianluigi Tanda, Paola Fadda · 2018 · Medicines
  65. Characterization of the endocannabinoid system in subcutaneous adipose tissue in periparturient dairy cows and its association to metabolic profiles
    Maya Zachut, Gitit Kra, Uzi Moallem, Lilya Livshitz, Yishai Levin, Shiran Udi, Alina Nemirovski, Joseph Tam · 2018 · PLoS ONE
  66. Effect of maternal under-nutrition on pup body weight and hypothalamic endocannabinoid levels
    Isabel Matias, Marion Léonhardt, Jean Lésage · 2003 · Cellular and Molecular Life Sciences
  67. Endocannabinoid structure–activity relationships for interaction at the cannabinoid receptors
    Patricia H. Reggio · 2002 · Prostaglandins Leukotrienes and Essential Fatty Acids
  68. Chemotaxis of Human Peripheral Blood Eosinophils to 2-Arachidonoylglycerol: Comparison with Other Eosinophil Chemoattractants
    Seishi Kishimoto, Saori Oka, Maiko Gokoh · 2006 · International Archives of Allergy and Immunology
  69. The Role of Cannabinoids in Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke
    Alessandro Pini, Guido Mannaioni, Domenico Edoardo Pellegrini-Giampietro, Maria Beatrice Passani, Rosanna Mastroianni, Danièle Bani, Emanuela Masini · 2012 · Current Drug Targets
  70. Inhibition of monoacylglycerol lipase reduces nicotine withdrawal
    Pretal P. Muldoon, Jingchun Chen, JoLynne Harenza, Rehab A. Abdullah, Laura J. Sim‐Selley, Benjamin F. Cravatt, Michael F. Miles, X Chen, Aron H. Lichtman, Mohamad Imad Damaj · 2014 · British Journal of Pharmacology
  71. Dronabinol and chronic pain: importance of mechanistic considerations
    Marjan de Vries, Dagmar C. van Rijckevorsel, Oliver H.G. Wilder‐Smith, Harry van Goor · 2014 · Expert Opinion on Pharmacotherapy
  72. Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development
    Charu Sharma, Bassem Shaban Sadek, Sameer N. Goyal, Satyesh K. Sinha, Mohammad Amjad Kamal, Shreesh Kumar Ojha · 2015 · Evidence-based Complementary and Alternative Medicine
  73. Cannabinoids in the Cardiovascular System
    W.‐S. Vanessa Ho, Melanie E.M. Kelly · 2017 · Advances in pharmacology
  74. The endocannabinoid system and stroke: A focused review
    Gary Benjamin Rajah, Bradley L. Kolb, Hamidreza Saber, Hassan A. Fadel · 2019 · Brain Circulation
  75. Pathogenic mechanisms of lipid mediator lysophosphatidic acid in chronic pain
    Hiroshi Ueda · 2020 · Progress in Lipid Research
  76. Perinatal CBD or THC Exposure Results in Lasting Resistance to Fluoxetine in the Forced Swim Test: Reversal by Fatty Acid Amide Hydrolase Inhibition
    Izaque de Sousa Maciel, Gabriel H Dias de Abreu, Claire T. Johnson, Rida Bonday, Heather B. Bradshaw, Ken Mackie, Hui‐Chen Lu · 2021 · Cannabis and Cannabinoid Research
  77. The Endocannabinoid System: A New Molecular Target for the Treatment of Tobacco Addiction
    María Scherma, Paola Fadda, Bernard Le Foll, Benoît Forget, Walter Fratta, Steven R. Goldberg, Gianluigi Tanda · 2008 · CNS & Neurological Disorders - Drug Targets
  78. Physiological roles of 2‐arachidonoylglycerol, an endogenous cannabinoid receptor ligand
    Takayuki Sugiura · 2009 · BioFactors
  79. Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse
    Candice E. Van Skike, Sarah E. Maggio, Anna R. Reynolds, Erin M. Casey, Michael Thomas Bardo, Linda P. Dwoskin, Mark Prendergast, Kimberly Nixon · 2015 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  80. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors
    María Luz López-Rodríguez, Alma Viso, Silvia Ortega‐Gutiérrez, Christopher John Fowler, Gunnar Tiger, Eva de Lago, Javier Fernández‐Ruíz, José Antonio Ramos · 2003 · European Journal of Medicinal Chemistry
  81. A new role of anandamide in human sperm: Focus on metabolism
    Saveria Aquila, Carmela Guido, Chiara Laezza, Antonietta Santoro, Vincenzo Pezzi, Salvatore Panza, Sebastiano Andò, Maurizio Bifulco · 2009 · Journal of Cellular Physiology
  82. Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study
    Laura Kranaster, Carolin Hoyer, Suna Su Aksay, Jan Malte Bumb, F. Markus Leweke, Christoph Janke, Manfred Thiel, Beat Lutz, Laura Bîndilă, Alexander Sartorius · 2017 · European Archives of Psychiatry and Clinical Neuroscience
  83. Palmitoylethanolamide: A Potential Alternative to Cannabidiol
    Paul Clayton, Silma Subah, Ruchitha Venkatesh, Mariko Hill, Nathasha Omal Bogoda · 2021 · Journal of Dietary Supplements
  84. Early exposure to environmental enrichment alters the expression of genes of the endocannabinoid system
    Rana El Rawas, Nathalie Thiriet, Joëlle Nader, Virginie Lardeux, Mohamed Jaber, Marcello Solinas · 2011 · Brain Research
  85. The Endocannabinoid/Endovanilloid System and Depression
    Irena Smaga, Beata Bystrowska, Dawid Gawliński, Edmund Przegaliński, Małgorzata Filip · 2014 · Current Neuropharmacology
  86. Contribution of CB1 blockade to the management of high-risk abdominal obesity
    Jean‐Pierre Després, Isabelle Lemieux, Natalie Alméras · 2006 · International Journal of Obesity
  87. Distribution of diacylglycerol lipase alpha, an endocannabinoid synthesizing enzyme, in the rat forebrain
    Juan Suárez, Óscar Ortiz, Nagore Puente, Francisco Javier Bermúdez‐Silva, Eduardo Blanco, Pedro Fernández‐Llebrez, Pedro Grandes, Fernando Rodrı́guez de Fonseca, Rosario Moratalla · 2011 · Neuroscience
  88. The Multiple Pathways of Endocannabinoid Metabolism: A Zoom Out
    Séverine Vandevoorde, Didier M. Lambert · 2007 · Chemistry & Biodiversity
  89. For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
    Rebecca J. Henry, Daniel M. Kerr, David P. Finn, Michelle Roche · 2015 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  90. Δ9-Tetrahydrocannabinol and Endocannabinoid Degradative Enzyme Inhibitors Attenuate Intracranial Self-Stimulation in Mice
    Jason M. Wiebelhaus, Travis W. Grim, Robert A. Owens, Matthew F. Lazenka, Laura J. Sim‐Selley, Rehab A. Abdullah, Micah J. Niphakis, Robert E. Vann, Benjamin F. Cravatt, Jenny L. Wiley et al. · 2014 · Journal of Pharmacology and Experimental Therapeutics
  91. The role of endocannabinoids in pregnancy
    Hsiu‐Wen Chan, Natalie C. McKirdy, Hassendrini N. Peiris, Gregory Edward Rice, Murray David Mitchell · 2013 · Reproduction
  92. Modulation of the Endocannabinoid System: Vulnerability Factor and New Treatment Target for Stimulant Addiction
    Stéphanie Olière, Antoine Joliette-Riopel, Stéphane Potvin, Didier Jutras‐Aswad · 2013 · Frontiers in Psychiatry
  93. Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs
    Luara A. Batista, Pedro Henrique Gobira, Thércia Guedes Viana, Daniele Cristina de Aguiar, Fabrício A. Moreira · 2014 · Behavioural Pharmacology
  94. The endocannabinoid system – current implications for drug development
    Christopher John Fowler · 2020 · Journal of Internal Medicine
  95. The role of endocannabinoid pathway in the neuropathology of Alzheimer’s disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer’s disease?
    Shivanshu Bajaj, Shreshta Jain, Preeti Vyas, Sandhya Bawa, Divya Vohora · 2021 · Brain Research Bulletin
  96. Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
    Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela Carmen Ababei, Mădălina Larion, Walther Bild, Gabriela Dumitriţa Stanciu, Carmen Solcan, Veronica Bild · 2022 · Biology
  97. Metabolic Messengers: endocannabinoids
    Arnau Busquets-García, Juan Pedro Bolaños, Giovanni Marsicano · 2022 · Nature Metabolism
  98. An Overview on the Biochemistry of the Cannabinoid System
    María Gómez‐Ruíz, Mariluz Hernández, Rosario de Miguel, José Antonio Ramos · 2007 · Molecular Neurobiology
  99. Ex Vivo Imaging of Fatty Acid Amide Hydrolase Activity and Its Inhibition in the Mouse Brain
    Glaser, Sherrye T., Gatley, S. John, Gifford, Andrew N. · 2006 · The Journal of Pharmacology and Experimental Therapeutics
  100. Double dissociation of monoacylglycerol lipase inhibition and CB1 antagonism in the central amygdala, basolateral amygdala, and the interoceptive insular cortex on the affective properties of acute naloxone-precipitated morphine withdrawal in rats
    Wills, Kiri L, Petrie, Gavin N, Millett, Geneva, Limebeer, Cheryl L, Rock, Erin M, Niphakis, Micah J, Cravatt, Benjamin F, Parker, Linda A · 2016 · Neuropsychopharmacology